Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective? / Hughes, D.; Hughes, D.A.; Pirmohamed, M.
Yn: Value in Health, Cyfrol 6, Rhif 6, 01.11.2003, t. 749.
Yn: Value in Health, Cyfrol 6, Rhif 6, 01.11.2003, t. 749.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
Hughes, D, Hughes, DA & Pirmohamed, M 2003, 'Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?', Value in Health, cyfrol. 6, rhif 6, tt. 749.
APA
Hughes, D., Hughes, D. A., & Pirmohamed, M. (2003). Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective? Value in Health, 6(6), 749.
CBE
Hughes D, Hughes DA, Pirmohamed M. 2003. Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?. Value in Health. 6(6):749.
MLA
Hughes, D., D.A. Hughes a M. Pirmohamed. "Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?". Value in Health. 2003, 6(6). 749.
VancouverVancouver
Hughes D, Hughes DA, Pirmohamed M. Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective? Value in Health. 2003 Tach 1;6(6):749.
Author
RIS
TY - JOUR
T1 - Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?
AU - Hughes, D.
AU - Hughes, D.A.
AU - Pirmohamed, M.
PY - 2003/11/1
Y1 - 2003/11/1
M3 - Article
VL - 6
SP - 749
JO - Value in Health
JF - Value in Health
SN - 1524-4733
IS - 6
ER -